Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurokeeper Technologies has developed a portable, head-worn device that uses EEG to rapidly detect strokes by analyzing brain wave patterns. The company’s technology is designed to provide early diagnosis in emergency settings. Clinical validation studies have been conducted at multiple academic centers, focusing on both concussion/mild TBI populations and patients at risk for stroke. The company is positioned within the growing field of neurological diagnostic devices aiming to improve outcomes through faster identification of critical events like stroke or TBI.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neurokeeper Technologies.